Guide · Updated September 2026

GLP-1 Prior Authorization: Requirements, Documentation, Timeline

Q: Do I need to document a weight-loss attempt before requesting a GLP-1?

Many plans want documented evidence of a structured diet, counseling, or supervised weight-loss attempt, commonly cited around three to six months, before approving the weight-management indication.

Prior authorization means your insurer wants proof, in writing from your prescriber, that you meet its clinical criteria before it pays for a GLP-1. Most denials trace back to one thing: the chart didn't document what the plan asked for. Here's what a prior authorization request actually needs, roughly how long plans take to decide, and what changes at renewal time.

Prior authorization (PA) is not a formality your prescriber’s office clicks through. It’s a real utilization-management review, and the plans running it have specific documentation they’re looking for. When people tell me their PA got denied, the reason is almost always missing or incomplete documentation rather than genuine ineligibility. This guide covers what to get into the chart before the request goes in.

Prior Authorization at a Glance

Question	Typical Answer
What triggers it?	Your plan requires clinical proof of medical necessity before covering a GLP-1, most often for the weight-management indication
Who submits it?	Your prescriber’s office, through the plan’s PA portal or fax
Core documentation	Current BMI (and weight-related condition if BMI is 27-29.9), weight history, relevant labs, a letter of medical necessity
Lifestyle-effort documentation	Many plans want a record of a structured diet, counseling, or supervised weight-loss attempt, commonly a few months, before approving
Decision timing	Varies by plan and request type. Ask your specific plan for its stated standard and expedited turnaround, and keep the reference number
Renewal	Many plans require reauthorization on a set schedule with documented ongoing treatment response
If denied	You can appeal using the specific denial reason. See our appeal letter template

General patterns compiled from plan documentation and pharmacy-benefit sources as of September 2026. Every plan writes its own policy. Ask your insurer for its exact criteria for your specific drug and diagnosis before assuming any figure here applies to you.

Why Insurers Require It

A GLP-1 prescription alone doesn’t tell your insurer why you need the specific drug at the specific dose your prescriber wrote. Prior authorization is the plan’s way of confirming that the prescription matches its coverage policy before it pays out on what is, for the weight-management indication especially, an expensive ongoing prescription. It’s separate from step therapy, which asks whether you’ve tried a cheaper alternative first. Plans frequently require both for the same prescription: PA to establish that you meet the clinical criteria, step therapy to establish that a cheaper option was tried. See our step therapy guide if your denial mentions a “step” drug instead of documentation.

The specific criteria differ depending on which FDA-approved use your prescription is for:

Weight management (Wegovy, Zepbound, Foundayo, Saxenda): built around the BMI 30+/27-29.9-plus-condition structure. Our BMI eligibility chart covers the exact thresholds by drug.
Type 2 diabetes (Ozempic, Mounjaro, and off-label diabetes use of other GLP-1s): built around A1C levels and, often, documented metformin use first. See our diabetes vs. weight loss guide for how these criteria diverge.

What Documentation Actually Goes Into the Request

A prior authorization submission is only as strong as what’s already in your chart. What plans commonly ask for:

Current BMI, dated recently. Most plans want your BMI documented in your medical record within a defined recent window, commonly the past 12 months. An outdated or missing BMI in the chart is one of the most avoidable reasons a request stalls.

The specific weight-related condition, if you’re in the 27-29.9 range. A diagnosis code alone isn’t always enough. Plans generally want to see the condition documented and, where relevant, actively managed, such as a blood pressure reading or a lipid panel, not just listed in your history.

Weight history. Your starting weight and recent weight trend, which also becomes the baseline your plan compares against at renewal.

Evidence of a structured weight-loss attempt. This is the piece people most often skip. Many plans want documentation of a period of diet, exercise counseling, or a supervised weight-loss program, commonly cited around three to six months, with a note on the outcome. Self-directed attempts you never discussed with a clinician typically don’t count toward this, because there’s nothing in a chart to point to. If you’ve been working with a doctor or dietitian on this already, ask them to document the specific dates and outcome before the PA goes in.

Relevant labs. A1C for a diabetes-track request, a lipid panel or other labs relevant to a documented comorbidity for a weight-management request.

A letter of medical necessity. Your prescriber’s written explanation connecting your specific diagnosis, BMI or A1C, and treatment history to the requested drug and dose.

Want the exact BMI and comorbidity thresholds first?

See the BMI Eligibility Chart →

How Long a Decision Takes

There’s no single national turnaround time. It depends on your plan, whether the request goes through electronic prior authorization or fax, whether it’s a standard or expedited review, and state-specific rules that set maximum response windows for certain plan types. Ask your insurer directly what its standard and expedited turnaround times are for this specific request, and get that in writing or note the representative’s name and the call date. Keep the submission reference number so you can follow up if the stated deadline passes without a decision.

If your situation is urgent, meaning a documented medical reason the wait itself creates risk, ask specifically about expedited review. Not every request qualifies, and the plan will tell you what does.

What Happens After Approval

An approved prior authorization is usually good for a defined period, not indefinitely, and it’s typically tied to the specific drug and sometimes the dose your prescriber requested. That has a few practical implications:

Switching drugs restarts the process. If you and your prescriber decide to switch from, say, semaglutide to tirzepatide, the existing PA generally doesn’t carry over. Expect a new submission.
Dose increases can trigger a new review on some plans, particularly if the higher dose sits in a different pricing tier.
PA approval and formulary tier are different things. Being approved doesn’t mean your copay is low. Check our formulary tiers guide for how tier placement affects what you actually pay once the PA clears.

Renewal and Reauthorization

Most plans that require an initial PA also require periodic reauthorization to keep covering the prescription, commonly on an annual or more frequent cycle depending on the plan. The renewal typically asks for documented ongoing treatment response rather than re-proving the original eligibility criteria from scratch. Some plans reference a documented amount of weight loss from your original baseline weight as evidence the treatment is working, though the exact percentage and time frame are plan-specific and not standardized industry-wide. This is why the baseline weight documented at your first PA matters. It’s the number renewal gets measured against.

If the renewal is denied for insufficient response, ask your prescriber whether the reason cited (weight plateau, dose still being titrated, a documented medical reason weight loss has been slower) can be addressed in an appeal, the same way an initial denial can.

If You’re Denied

Read the specific reason on the written denial notice before assuming the worst. Common, addressable reasons include a missing or outdated BMI in the chart, a diagnosis code that doesn’t match the plan’s covered indication, missing lifestyle-attempt documentation, or a step therapy requirement that wasn’t met. Our appeal letter template walks through the internal appeal process and what to include for the most common denial reasons.

Denied or still waiting? Compare cash-pay options while you sort it out.

See Cash-Pay Prices →

Bottom Line

A GLP-1 prior authorization request succeeds or fails mostly on documentation: a current BMI or A1C in the chart, the specific comorbidity if you’re in the 27-29.9 BMI range, evidence of a structured weight-loss attempt if your plan asks for one, and a letter connecting all of it to the requested drug. There’s no universal turnaround time or renewal threshold, so get your plan’s specific written policy rather than assuming a number from a forum or a different insurer’s rules. If it’s denied, the written reason tells you exactly what to fix.

FAQ

What’s the difference between prior authorization and step therapy?

Prior authorization asks your prescriber to document that you meet the plan’s clinical criteria, like BMI and comorbidities, for the drug you’re requesting. Step therapy separately asks you to have already tried a cheaper drug first. Plans often require both for the same prescription.

How long does GLP-1 prior authorization take?

There’s no single standard timeline. It depends on your plan, the submission method, whether it’s a standard or expedited request, and state rules that apply to your plan type. Ask your insurer for its stated standard and expedited turnaround and keep the reference number.

Do I need to document a weight-loss attempt before requesting a GLP-1?

Many plans want to see documented evidence of a structured diet, counseling, or supervised weight-loss attempt, commonly cited around three to six months, before approving the weight-management indication. Self-directed attempts that were never discussed with a clinician typically don’t satisfy this because there’s no chart documentation to reference.

Does an approved prior authorization cover a dose increase or a drug switch?

Not automatically. PA approvals are usually tied to the specific drug and sometimes the dose requested. A dose increase or a switch to a different GLP-1 commonly requires a new submission.

What do plans check at renewal?

Most plans require periodic reauthorization with documentation of ongoing treatment response rather than re-proving the original eligibility criteria. Some reference a documented percentage of weight loss from your original baseline, though the exact threshold varies by plan.

Guides:

Tools:

Insurance Coverage Checker

Compare: All Providers